Regulaxis Is A French Innovative Biotechnology Company Based At Biocitech The Technology Park Of Life Science Of Paris North Areathe Company Is Engaged In The Researchdevelopment And Licensing Of Innovative Synthetic Molecules For Use In Human Therapiesits Mission Is To Grant Licenses Of Innovative Molecules In A Pharmaceutical Company After The Establishment Of A Phase Ii Clinical Recordregulaxis Leads Its R&D On Its Own Premisesparticularly In Regard To Biochemical And Biological Experimentsand Keeps The Mastery Of The Chemical Synthesis Of Its Therapeutic Moleculesthe Company Develops Its Molecules Alone Or In Establishing Targeted Collaborations With Academic Researchersor Also In Partnerships With Companies Interested In Developing Its Own Therapeutic Molecules
